metadata toggle
Uses
Synulox Palatable Tablets have a broad spectrum of activity against bacteria commonly found in dogs.
In vitro Synulox is active against a wide range of clinically important aerobic and anaerobic bacteria, including:
Gram-positive
Staphylococci (including beta-lactamase-producing strains), Clostridia, Actinomyces, Peptostreptococcus spp., Streptococci, Enterococci
Gram-negative
Bacteroides spp. (including β-lactamase-producing strains), Escherichia coli (including beta-lactamase-producing strains), Salmonellae (including β-lactamase-producing strains), Bordetella bronchiseptica, Campylobacter spp., Fusobacterium necrophorum, Klebsiellae, Pasteurellae, Proteus spp.
Clinically, Synulox has been shown to be effective in treating a wide range of diseases of dogs including: Skin disease (including deep and superficial pyoderma); urinary tract infection; respiratory disease involving upper and lower respiratory tract, enteritis, dental infections (e.g. gingivitis), soft tissue infections (e.g. abscesses and anal sacculitis).
Note: Synulox is not indicated for cases involving Pseudomonas spp.